Kymera Therapeutics has seen a sharp reset in long term expectations, with the fair value estimate jumping from $77.59 to $114.00 even as modeled revenue growth is revised down from roughly -0.04% to ...
Gold price eases as XAUUSD traders wait on U.S. jobs data, with resistance at $4353.56 and buy-the-dip support holding near ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback